NTT Electronics Contributes Goldstone - Open Source Network OS for Disaggregated Coherent Transponders to the Telecom Infra Project
13.11.2019 09:00:00 EET | Business Wire | Press release
NTT Electronics, a leading provider of advanced components for optical communications systems including coherent optics and digital signal processors (DSPs), contributes the Goldstone Network Operating Software (NOS *1) for disaggregated coherent transponders to the Telecom Infra Project’s NOS Software Project hosted by the Open Optical and Packet Transport project group. Launched in February 2016, TIP was started with the goal of accelerating the pace of innovation in the telecom industry.
Goldstone utilizes many existing open source components which have been developed in Open Compute Project (OCP *2) and Telecom Infra Project (TIP *3) including Open Network Linux (ONL *4), SONiC *5, Switch Abstraction Interface (SAI *6) and Transponder Abstraction Interface (TAI *7) to provide a full-fledged open source solution. ONL is used as the base operating system and provides a wide range of open network device support. On top of ONL, Kubernetes *8 is employed to enable containerized application management, which realizes flexible and modular software composition. SONiC/SAI is deployed as a fleet of containers when the target hardware comprises Ethernet switch ASIC, whereas TAI is used when the target hardware has coherent transponder components. Because of its modular architecture, Goldstone can be extended to support networking devices, which don’t have Ethernet ASIC, but may include conventional transponders, ROADMs or amplifiers in the future.
Goldstone was originally started as a prototype NOS for Edgecore’s Cassini Platform by the proposal from NTT Electronics. This has led to a production deployment by mixi in Japan.
More than five industry partners are using Goldstone for evaluation on the Cassini platform.
It is also being incorporated in Wistron’s Galileo platform.
The NOS is planned to be contributed to TIP Open Optical Packet Transport (OOPT *9) group as an open source project. Goldstone is planned to be part of a live running demonstration at the TIP Summit 2019.
Quote from mixi, Inc.
“As the first operator who deployed Goldstone in production, mixi welcomes the contribution of Goldstone by NTT Electronics to foster more collaboration among the open networking industry. Goldstone brought us huge flexibility and control over our DCI connectivity which is critical for our services” Tatsuma Murase, CTO, mixi, Inc.
Quote from Edgecore
“Edgecore is pleased to be working with NTT Electronics and the broader industry community to enable disaggregated solutions with open packet transponders that will provide broader optical technology choices for network operators.” George Tchaparian, President and CEO, Edgecore Networks
Quote from Wistron
“Wistron is excited to have Goldstone in the open networking industry. Goldstone will accelerate the adaptation of the open disaggregated networking model and we believe it will become a viable solution together with our latest Galileo platform.” Arthur Chang, Sr. Technical Director, Wistron
*1 Network Operating System (NOS) : Operating system for a network device such as a router, switch or firewall.
*2 Open Compute Project (OCP) : The Open Compute Project (OCP) is a collaborative community focused on redesigning hardware technology to efficiently support the growing demands on compute infrastructure. In 2011, Facebook shared its designs with the public and launched the Open Compute Project and incorporated the Open Compute Project Foundation along with Intel, Rackspace, Goldman Sachs and Andy Bechtolsheim. (Reference: OCP web site: https://www.opencompute.org/)
*3 Telecom Infra Project (TIP) : The Telecom Infra Project (TIP) is a collaborative telecom community founded by Facebook and partners. Launched in February 2016, TIP was started with the goal of accelerating the pace of innovation in the telecom industry. TIP members include operators, suppliers, developers, integrators, startups, and other entities that have joined TIP to build new technologies and develop innovative approaches for deploying telecom network infrastructure. (Reference: TIP web site: https://telecominfraproject.com/)
*4 Open Network Linux (ONL) : Open Network Linux(ONL) is an open-source, foundational platform software layer for next-generation, modular NOS architecture on open networking hardware. ONL is a part of the Open Compute Project and is a component in a growing number of commercial NOS stacks and open source projects like CoRD & Stratum. (Reference: ONL web site : http://opennetlinux.org/)
*5 Software for Open Networking in the Cloud (SONiC) : Open source software developed by Microsoft, etc.. It dramatically enhances operations and management of network switches. (Reference: SONiC repository: http://azure.github.io/SONiC/)
*6 Switch Abstraction Interface (SAI) : The Switch Abstraction Interface (SAI) defines the API to provide a vendor-independent way of controlling forwarding elements, such as a switching ASIC, an NPU or a software switch in a uniform manner. (Reference: SAI repository: https://github.com/opencomputeproject/SAI)
*7 Transponder Abstraction Interface (TAI) : The Transponder Abstraction Interface (TAI) is the open API to provide a vendor-independent way of controlling coherent optical components. TAI has been developed under TIP OOPT group and NTT is leading the development. https://www.ntt.co.jp/news2018/1810e/181016c.html
*8 Kubernetes : Kubernetes is a portable, extensible, open-source platform for managing containerized workloads and services. Google open-sourced the Kubernetes in 2014. (Reference: Kubernetes web site : https://kubernetes.io/)
*9 Open Optical Packet Transport (OOPT) : The Open Optical & Packet Transport project group will define Dense Wavelength Division Multiplexing (DWDM) open packet transport architecture that triggers new innovation and avoids implementation lock-ins. Open DWDM systems include open line system & control, transponder & network management and packet-switch and router technologies. (Reference: TIP web site: https://telecominfraproject.com/oopt/)
About NTT Electronics
NTT Electronics (NEL) has been developing and commercializing optical communications devices since 1995. It has complete portfolio of optical and electronics products to cover the industry needs for 100G-and-beyond link systems, ROADM components and FTTH networks. For more information about NEL, visit https://www.ntt-electronics.com/en/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191112006191/en/
Contact information
Media Contacts:
Atul Srivastava, Chief Technical Officer
NTT Electronics America, Inc.
Email : pr@nel-america.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer31.8.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the second interim analysis (IA2) of the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), in combination with chemotherapy, with and without TEVIMBRA® (tislelizumab), as first-line treatment for HER2+ locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). At IA2, ZIIHERA plus chemotherapy demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) compared with trastuzumab plus chemotherapy, meeting the remaining primary endpoint analysis of the study. IA2 also provided longer follow-up data for the TEVIMBRA plus ZIIHERA and chemotherapy regimen, demonstrating an improved OS hazard ratio, continued durable outcomes, and a generally manageable safety profile. These results reinforce findings from IA1, in which the regimen met the progression-free survival (PFS) and OS endpoints, wi
GigaDevice Strengthens EMEA and Southeast Asia Market Reach Through Strategic Partnership with Rutronik31.8.2026 10:00:00 EEST | Press release
GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, today announced a new strategic franchise partnership with Rutronik Elektronische Bauelemente GmbH, one of Europe’s leading broadline distributors of electronic components. The agreement covers EMEA and Southeast Asia, including India, and provides customers with broader access to GigaDevice’s comprehensive portfolio of microcontrollers, sensors, and power management solutions. The partnership further strengthens GigaDevice’s distribution network and local market presence across key regions. With its strong presence across Europe and growing coverage in Southeast Asia, Rutronik provides GigaDevice with an established channel supported by extensive market reach, technical expertise, and customer relationships. The collaboration will help expand access to GigaDevice’s embedded solutions across a broad range of applications and industries, including indus
Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings30.8.2026 15:23:00 EEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR) patient populations, treatment settings, and manifestations of disease. Additionally, the data expand the potential application of RNAi to uncontrolled hypertension, the world’s leading cause of cardiovascular disease. “With the power of our RNAi therapeutics platform, we have the potential to make a transformational impact on cardiovascular care,” said Pushkal Garg, M.D., Chief Research and Development Officer at Alnylam. “The data presented at ESC demonstrate the consistency of clinical outcomes achieved by RNAi-powered TTR silencing, reinforcing our conviction in AMVUTTRA as a first-line treatment option for ATTR-CM. With
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202630.8.2026 00:54:00 EEST | Press release
Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon company, in strategic partnership with the Emirates Falconers’ Club, at ADNEC Centre Abu Dhabi. The exhibition runs until 6 September. The falcon, owned
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 01:40:00 EEST | Press release
Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the total amount of blood in the body. Maintaining controlled hematocrit levels below 45% is the primary treatment goal in PV.1 “For patients living with PV, uncontrolled hematocrit can have serious consequences, including an elevated risk of life-threatening thrombotic events," said Andrew T. Kuykendall, M.D., VERIFY lead investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “Curre
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
